MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 164481 to 164500 of 166,322 approvalsPage 8225 of 8317

Povidone Iodine Solution

Approval Number: 国药准字H51020491
Registration: Sep 30, 2019

Pazufloxacin Mesilate Injection

Approval Number: 国药准字H20090341
Registration: Sep 30, 2019

Ibuprofen Sustained-release Capsules

Approval Number: 国药准字H20093835
Registration: Sep 30, 2019

Povidone Iodine Solution

Approval Number: 国药准字H51020422
Registration: Sep 30, 2019

Compound Electrolytes and Glucose Injection MG3

Approval Number: 国药准字H20103074
Registration: Sep 30, 2019

Apatinib Mesylate Tablets

Approval Number: 国药准字H20140103
Registration: Sep 30, 2019

Simvastatin Tablets

Approval Number: 国药准字H20093985
Registration: Sep 30, 2019

抗菌消炎胶囊

Approval Number: 国药准字Z20090512
Registration: Sep 30, 2019

Ambroxol Hydrochloride Sustained Release Capsules

Approval Number: 国药准字H20153016
Registration: Sep 30, 2019

莱阳梨止咳糖浆

Approval Number: 国药准字Z37021016
Registration: Sep 30, 2019

Oxymetazoline Hydrochloride Eye Drops

Approval Number: 国药准字H20093981
Registration: Sep 30, 2019

四逆汤

Approval Number: 国药准字Z37021256
Registration: Sep 30, 2019

Cefotiam Hydrochloride for Injection

Approval Number: 国药准字H20123021
Registration: Sep 30, 2019

生脉饮

Approval Number: 国药准字Z37021017
Registration: Sep 30, 2019

Levofloxacin Lactate Tablets

Approval Number: 国药准字H20093964
Registration: Sep 30, 2019

Cefotiam Hydrochloride for Injection

Approval Number: 国药准字H20094217
Registration: Sep 30, 2019

Apatinib Mesylate Tablets

Approval Number: 国药准字H20140105
Registration: Sep 30, 2019

Amoxicillin Sodium and Sulbactam Sodium for Injection

Approval Number: H20130529
Registration: Sep 30, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.